Posted By: CITI Program Staff Posted On: July 17, 2025
“What CITI Program is Reading” is our biweekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare, technology, and more. Follow us on LinkedIn for upcoming editions and more information from CITI Program.
Research
Exclusive: NIH suspends dozens of pathogen studies over ‘gain-of-function’ concernsSource: ScienceTrump executive order leads to pauses on U.S.-funded research into TB, influenza, COVID-19, and other diseases, dismaying some scientists.
A million veterans gave DNA for medical research. Now the data is in limboSource: NPRRetired service members donated genetic material to a DNA database to help answer health questions for all Americans. The Trump administration is dragging its heels on agreements to analyze the data.
Read The Full Article
I worked for 20 years for the HHS office that safeguarded people in research studies. DOGE gutted itSource: STATWith fewer human research protection program staff in research institutions, mistakes will be made, and no one might be there to fix them.
University Leaders Propose New Research Funding ModelSource: Inside Higher EdSome lawmakers and the Trump administration have criticized the government’s long-standing model for reimbursing universities for indirect research costs.
US Senate Drops Proposed Moratorium on State AI Laws in Budget VoteSource: Tech Policy PressThe 99-1 vote followed the collapse of a compromise between Senators Ted Cruz (R-TX) and Marsha Blackburn (R-TN).
Read The Full Article
'Positive review only': Researchers hide AI prompts in papersSource: Nikkei AsiaInstructions in preprints from 14 universities highlight controversy on AI in peer review.
Disclosing generative AI use for writing assistance should be voluntarySource: Sage JournalsResearchers have been using generative artificial intelligence (GenAI) to support writing manuscripts for several years now.
Read The Full Article
Alphabet’s Isomorphic Labs has grand ambitions to ‘solve all diseases’ with AI. Now, it’s gearing up for its first human trialsSource: MSN“One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to address that disease,” Colin Murdoch, Isomorphic Labs president and Google DeepMind's chief business officer said.
Read The Full Article
Safety
Chemistry, Regulatory, & Performance Aspects Of Antimicrobials For HVAC&R ComponentsSource: ASHRAELearn more about July 2025 Chemistry, Regulatory, & Performance Aspects Of Antimicrobials For HVAC&R Components at ashrae.org.
Biosafety concept: Origins, evolution, and prospectsSource: ScienceDirectBiosafety is essential to ensuring the safe and effective conduct of biological research by minimizing risks associated with laboratory work and biological materials.
Read The Full Article
Compliance
HHS eases regulations on EHR vendorsSource: Becker's Hospital ReviewHHS’ assistant secretary for technology policy/ONC is easing testing requirements on EHR companies.
Read The Full Article